Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FZX78
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,249
Award facts
- Contract value 100% obligated
- $6,248.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,248.70 by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order, which has an ultimate completion date of September 25, 2025, was issued without a set-aside designation, allowing the vendor to compete on an unrestricted basis. The award leverages DMS Pharmaceutical Group's existing indefinite delivery contract with the DLA under the SPE2DB program, a single-award vehicle valued at $499,999,999 and valid through November 2026 that enables the agency to procure pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
As a crucial supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group maintains a robust portfolio of federal contracts covering prescription medications, biologics, and medical consumables distributed to military and federal healthcare systems. The Nexplanon implants delivered under this order represent a contraceptive pharmaceutical product within the company's broader specialization in supplying branded and generic drugs, over-the-counter medications, and specialty pharmaceutical items. This delivery order exemplifies the company's established position as a primary source for DLA pharmaceutical procurement, supporting the agency's mission to provide comprehensive medical supply distribution to Department of Defense healthcare sites globally.
Quick answers
Who was awarded contract SPE2DB25FZX78?
SPE2DB25FZX78 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FZX78 worth?
The government has obligated $6,249 on SPE2DB25FZX78.
Is contract SPE2DB25FZX78 an order under another contract?
Yes. SPE2DB25FZX78 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX78 competed?
The extent of competition for SPE2DB25FZX78 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award